Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle.

Transgenic mice that overexpress insulin-like growth factor-1 (IGF-I) specifically in skeletal muscle have generated much information about the role of this factor for muscle growth and remodelling and provide insight for therapeutic applications of IGF-I for different pathological states and ageing. However, difficulties arise when attempting to critically compare the significance of data obtained in vivo by using different genetically engineered mouse lines and various experimental models. Complications arise due to complexity of the IGF-I system, since multiple transcripts of the IGF-I gene encode different isoforms generated by alternate promoter usage, differential splicing and post-translational modification, and how IGF-I gene expression relates to its diverse autocrine, paracrine and endocrine modes of action in vivo has still to be elucidated. In addition, there are problems related to specification of the exact IGF-I isoform used, expression patterns of the promoters, and availability of the transgene product under different experimental conditions. This review discusses the factors that must be considered when reconciling data from cumulative studies on IGF-I in striated muscle growth and differentiation using genetically modified mice. Critical evaluation of the literature focuses specifically on: (1) the importance of detailed information about the IGF-I isoforms and their mode of action (local, systemic or both); (2) expression pattern and strength of the promoters used to drive transgenic IGF-I in skeletal muscle cells (mono and multi-nucleated); (3) local compared with systemic action of the transgene product and possible indirect effects of transgenic IGF-I due to upregulation of other genes within skeletal muscle; (4) re-interpretation of these results in light of the most recent approaches to the dissection of IGF-I function. Full understanding of these complex in vivo issues is essential, not only for skeletal muscle but for many other tissues, in order to effectively extend observations derived from transgenic studies into potential clinical situations.

[1]  T. Toyofuku,et al.  Expression of α‐cardiac and α‐skeletal actin mRNAs in relation to innervation in regenerating and non‐regenerating rat skeletal muscles , 1992 .

[2]  D. Le Roith,et al.  Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. , 1997 .

[3]  M. Grounds,et al.  The onset of myogenesis in denervated mouse skeletal muscle regenerating after injury , 1989, Neuroscience.

[4]  J. Kornhauser,et al.  Myosin light chain enhancer activates muscle-specific, developmentally regulated gene expression in transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Rosenthal,et al.  Different modes of hypertrophy in skeletal muscle fibers , 2002, The Journal of cell biology.

[6]  C. Roberts,et al.  Insulin‐like Growth Factors , 1993, Biological signals.

[7]  Z. Upton,et al.  Purification, amino acid sequence and characterisation of kangaroo IGF-I. , 1998, The Journal of endocrinology.

[8]  J. Sanes,et al.  Fiber type- and position-dependent expression of a myosin light chain- CAT transgene detected with a novel histochemical stain for CAT , 1991, The Journal of cell biology.

[9]  B. Russell,et al.  Expression of insulin growth factor‐1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation , 1999, The Journal of physiology.

[10]  M. J. Dauncey,et al.  The porcine insulin-like growth factor-I gene: characterization and expression of alternate transcription sites. , 1993, Journal of molecular endocrinology.

[11]  C. Roberts,et al.  Insulin-like growth factor I messenger ribonucleic acids with alternative 5'-untranslated regions are differentially expressed during development of the rat. , 1989, Endocrinology.

[12]  C. Roberts,et al.  Transcription initiation in the two leader exons of the rat IGF-I gene occurs from disperse versus localized sites. , 1991, Biochemical and biophysical research communications.

[13]  D. Leroith,et al.  Protein calorie restriction affects nonhepatic IGF-I production and the lymphoid system: studies using the liver-specific IGF-I gene-deleted mouse model. , 2002, Endocrinology.

[14]  R. Schwartz,et al.  Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway. , 2000, The Journal of biological chemistry.

[15]  C. Roberts,et al.  Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. , 1987, Molecular endocrinology.

[16]  A. Musarò,et al.  Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Chew,et al.  An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. , 1995, Endocrinology.

[18]  J. Shay,et al.  Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology , 2000, Nature Medicine.

[19]  D. Leroith,et al.  Insulin-Like Growth Factor I Is Essential for Postnatal Growth in Response to Growth Hormone , 1999 .

[20]  Robert J. Schwartz,et al.  Myogenic Vector Expression of Insulin-like Growth Factor I Stimulates Muscle Cell Differentiation and Myofiber Hypertrophy in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.

[21]  B. Saltin,et al.  Net Fluxes Over Working Thigh of Hormones, Growth Factors and Biomarkers of Bone Metabolism During Short Lasting Dynamic Exercise , 1997, Calcified Tissue International.

[22]  K. Hall,et al.  A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor 1 (IGF-1). , 1989, Biochimica et biophysica acta.

[23]  R W Orrell,et al.  Expression of IGF‐I splice variants in young and old human skeletal muscle after high resistance exercise , 2003, The Journal of physiology.

[24]  N. Robbins,et al.  Cell proliferation in denervated muscle: Identity and origin of dividing cells , 1982, Neuroscience.

[25]  L. Donahue,et al.  Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. , 2000, Endocrinology.

[26]  H. Blau,et al.  Differential patterns of transcript accumulation during human myogenesis , 1987, Molecular and cellular biology.

[27]  H. Jörnvall,et al.  Isolation and characterization of variant IGF‐1 as well as IGF‐2 from adult human brain , 1986, FEBS letters.

[28]  R. Schwartz,et al.  Local insulin‐like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  S. Chew,et al.  Nucleolar localization of an isoform of the IGF-I precursor , 2002, BMC Cell Biology.

[30]  C. Roberts,et al.  Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: evidence for differential processing and regulation in liver. , 1988, Molecular endocrinology.

[31]  J. McGeachie.  The fate of proliferating cells in skeletal muscle after denervation or tenotomy: An autoradiographic study , 1985, Neuroscience.

[32]  Hamish Simpson,et al.  Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch , 1996, Journal of Muscle Research & Cell Motility.

[33]  M. Buckingham,et al.  Transcripts of alpha-cardiac and alpha-skeletal actins are early markers for myogenesis in the mouse embryo. , 1988, Development.

[34]  G. Bernardi,et al.  Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Roberts,et al.  Tissue-specific transcription start site usage in the leader exons of the rat insulin-like growth factor-I gene: evidence for differential regulation in the developing kidney. , 1992, Endocrinology.

[36]  C. Roberts,et al.  Differential expression of alternative 5' untranslated regions in mRNAs encoding rat insulin-like growth factor I. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Bernstein,et al.  Sequence of a cDNA encoding dog insulin-like growth factor I. , 1993, Gene.

[38]  C. Roberts,et al.  Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes. , 1991, Molecular endocrinology.

[39]  A. Krainer,et al.  General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. , 1993, Genes & development.

[40]  L. Olson,et al.  The Biological Role of Truncated Insulin‐like Growth Factor‐1 and the Tripeptide GPE in the Central Nervous System a , 1993, Annals of the New York Academy of Sciences.

[41]  C. Roberts,et al.  Alternative splicing produces messenger RNAs encoding insulin-like growth factor-I prohormones that are differentially glycosylated in vitro. , 1990, Molecular endocrinology.

[42]  P. Rotwein,et al.  Mosaic evolution of the insulin-like growth factors. Organization, sequence, and expression of the rat insulin-like growth factor I gene. , 1987, The Journal of biological chemistry.

[43]  R J Schwartz,et al.  Overexpression of IGF-I in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy. , 1998, The American journal of physiology.

[44]  G. Goldspink,et al.  Expression and Splicing of the Insulin‐Like Growth Factor Gene in Rodent Muscle is Associated with Muscle Satellite (stem) Cell Activation following Local Tissue Damage , 2003, The Journal of physiology.

[45]  D. Steiner,et al.  Mutational Analysis of the Insulin-like Growth Factor I Prohormone Processing Site (*) , 1995, The Journal of Biological Chemistry.

[46]  N. Rosenthal,et al.  Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[47]  D. Lu,et al.  Quantitative study of the effects of long‐term denervation on the extensor digitorum longus muscle of the rat , 1997, The Anatomical record.

[48]  C. Roberts,et al.  Insulin-like growth factors. , 1992, Biological signals.

[49]  Y. Nikiforov,et al.  Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. , 1997, The Journal of clinical investigation.

[50]  J. V. Van Wyk,et al.  The size heterogeneity of rat insulin-like growth factor-I mRNAs is due primarily to differences in the length of 3'-untranslated sequence. , 1989, Molecular endocrinology.

[51]  F. Gannon,et al.  Nucleotide sequence of the bovine insulin-like growth factor 1 (IGF-1) and its IGF-1A precursor. , 1990, Nucleic acids research.

[52]  D. Leroith,et al.  Effects of organ-specific loss of insulin-like growth factor-I production on murine hematopoiesis. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[53]  B. Li,et al.  Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Thomas Kazen.  Purification , 2004, Nature Biotechnology.

[55]  S. Yakar,et al.  The somatomedin hypothesis: 2001. , 2001, Endocrine reviews.

[56]  A. Musarò,et al.  Insulin-like growth factor isoforms in skeletal muscle aging, regeneration, and disease. , 2002, Cold Spring Harbor symposia on quantitative biology.

[57]  T. Shavlakadze,et al.  Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy , 2005, Neuromuscular Disorders.

[58]  C. Roberts,et al.  Insulin-like growth factor I (IGF-I): A molecular basis for endocrine versus local action? , 1991, Molecular and Cellular Endocrinology.

[59]  J. Wallace,et al.  Purification, amino acid sequences and assay cross-reactivities of porcine insulin-like growth factor-I and -II. , 1989, The Journal of endocrinology.

[60]  E. Rinderknecht,et al.  The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. , 1978, The Journal of biological chemistry.

[61]  R. Schwartz,et al.  Persistent IGF-I overexpression in skeletal muscle transiently enhances DNA accretion and growth. , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  M. Grounds.  Towards understanding skeletal muscle regeneration. , 1991, Pathology, research and practice.

[63]  Y. Le Bouc,et al.  Complete characterization of the human IGF‐I nucleotide sequence isolated from a newly constructed adult liver cDNA library , 1986, FEBS letters.

[64]  J. Mattick,et al.  The evolution of controlled multitasked gene networks: the role of introns and other noncoding RNAs in the development of complex organisms. , 2001, Molecular biology and evolution.

[65]  M. Bouxsein,et al.  Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. , 2004, The Journal of clinical investigation.

[66]  D. K. Didier,et al.  Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. , 1986, The Journal of biological chemistry.

[67]  D. Cocchi,et al.  Higher content of insulin-like growth factor-I in dystrophic mdx mouse: potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function , 1999, Neuromuscular Disorders.

[68]  G. Goldspink,et al.  Different roles of the IGF‐I Ec peptide (MGF) and mature IGF‐I in myoblast proliferation and differentiation , 2002, FEBS letters.

[69]  R. Gilmour,et al.  The ovine insulin-like growth factor-I gene: characterization, expression and identification of a putative promoter. , 1991, Journal of molecular endocrinology.

[70]  F. V. Schaik,et al.  Sequence of cDNA encoding human insulin-like growth factor I precursor , 1983, Nature.

[71]  A. Nordberg,et al.  Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide. , 1989, Biochemical and biophysical research communications.

[72]  G. Lynch,et al.  Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. , 2002, The American journal of pathology.

[73]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[74]  R. Schwartz,et al.  Targeted Expression of IGF‐1 Transgene to Skeletal Muscle Accelerates Muscle and Motor Neuron Regeneration , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  J. V. Van Wyk,et al.  Multiple transcription start sites in the rat insulin-like growth factor-I gene give rise to IGF-I mRNAs that encode different IGF-I precursors and are processed differently in vitro. , 1993, Growth factors.

[76]  A. Musarò,et al.  Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice , 2002, The Journal of cell biology.

[77]  Richard W. Orrell,et al.  Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise.[see comment] , 2003 .

[78]  Nucleotide sequence of a genomic fragment of the rat IGF-I gene spanning an alternate 5' non coding exon. , 1989, Nucleic acids research.

[79]  R. Schwartz,et al.  Insulin-like Growth Factor-I Extends in VitroReplicative Life Span of Skeletal Muscle Satellite Cells by Enhancing G1/S Cell Cycle Progression via the Activation of Phosphatidylinositol 3′-Kinase/Akt Signaling Pathway* , 2000, The Journal of Biological Chemistry.

[80]  T. Shavlakadze,et al.  Early Regeneration of Whole Skeletal Muscle Grafts Is Unaffected by Overexpression of IGF-1 in MLC/mIGF-1 Transgenic Mice , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[81]  G. Butler-Browne,et al.  Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children , 2000, Neuromuscular Disorders.

[82]  Antonio Musarò,et al.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.

[83]  G. I. Bell,et al.  Sequences of liver cDNAs encoding two different mouse insulin-like growth factor I precursors. , 1986, Nucleic acids research.

[84]  P. Rotwein,et al.  Two insulin-like growth factor I messenger RNAs are expressed in human liver. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[85]  J. Wallace,et al.  Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form. , 1988, The Biochemical journal.

[86]  C. Roberts,et al.  Alternative leader sequences in insulin-like growth factor I mRNAs modulate translational efficiency and encode multiple signal peptides. , 1995, Molecular endocrinology.

[87]  F. Haddad,et al.  Selected contribution: acute cellular and molecular responses to resistance exercise. , 2002, Journal of applied physiology.

[88]  J. Wallace,et al.  Sheep insulin-like growth factors I and II: sequences, activities and assays. , 1989, Endocrinology.

[89]  D. Burt,et al.  Tissue specific expression of an α-skeletal actin-lacZ fusion gene during development in transgenic mice , 2005, Transgenic Research.